Huntington's disease

Ayana Bio Awarded National Institutes of Health Grant to Harness Neuroprotective Benefits from Plant Cell-Cultivated Saffron

Retrieved on: 
수요일, 5월 1, 2024
Climate change, Bangladesh Technical Education Board, Huntington's disease, Saffron, NIH, Health, Flower, Weight loss, Research, Taste, Depression, Stainless steel, Plant, Alzheimer's disease, Alternative medicine, NCCIH, Anxiety, Spice

BOSTON, May 1, 2024 /PRNewswire/ -- Ayana Bio, the plant cell technology company dedicated to creating sustainable bioactives for consumer products, has received a grant from the National Center for Complementary and Integrative Health (NCCIH), part of the National Institutes of Health (NIH), to support Ayana Bio's research into the production of saffron's neuroprotective bioactives through plant cell cultivation.  

Key Points: 
  • BOSTON, May 1, 2024 /PRNewswire/ -- Ayana Bio , the plant cell technology company dedicated to creating sustainable bioactives for consumer products, has received a grant from the National Center for Complementary and Integrative Health (NCCIH), part of the National Institutes of Health (NIH), to support Ayana Bio's research into the production of saffron's neuroprotective bioactives through plant cell cultivation.
  • Saffron's neurological effects are also proven to aid in weight loss by increasing satiety , making it a powerful health ingredient with interconnected benefits.
  • The $300 thousand NIH grant will fund Ayana Bio's research to identify which complex of saffron bioactives can consistently demonstrate the highest neuroprotective benefits, specifically for Huntington's disease.
  • "Today's grant from the NIH is a validation of plant cell cultivation's ability to unlock botanicals like saffron's powerful benefits and improve health outcomes."

Neurocrine Biosciences Announces U.S. FDA Approval of INGREZZA® SPRINKLE (valbenazine) Capsules

Retrieved on: 
화요일, 4월 30, 2024
FDA, Capsule, Dysphagia, Neurocrine Biosciences, Huntington's disease, Food, Tardive dyskinesia, HD, Patient, Chemistry, Caregiver, VMAT2, Chorea, SAN, Pharmaceutical industry

SAN DIEGO, April 30, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the U.S. Food and Drug Administration has approved INGREZZA® SPRINKLE (valbenazine) capsules, a new oral granules formulation of INGREZZA® (valbenazine) capsules prescribed for the treatment of adults with tardive dyskinesia and chorea associated with Huntington's disease.1 INGREZZA SPRINKLE provides an alternative administration option for those who experience dysphagia or have difficulty swallowing.

Key Points: 
  • SAN DIEGO, April 30, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the U.S. Food and Drug Administration has approved INGREZZA® SPRINKLE (valbenazine) capsules, a new oral granules formulation of INGREZZA® (valbenazine) capsules prescribed for the treatment of adults with tardive dyskinesia and chorea associated with Huntington's disease.1 INGREZZA SPRINKLE provides an alternative administration option for those who experience dysphagia or have difficulty swallowing.
  • "We developed INGREZZA SPRINKLE to make administration easier for patients who have difficulty swallowing or prefer not to take a capsule," said Eiry W. Roberts, M.D., Chief Medical Officer at Neurocrine Biosciences.
  • "We are pleased to offer the proven efficacy of INGREZZA in reducing uncontrollable movements in a new formulation."
  • ‡,†
    The U.S. Food and Drug Administration (FDA) approval was based on chemistry, manufacturing, and controls information and data demonstrating the bioequivalence and tolerability of INGREZZA SPRINKLE compared to INGREZZA capsules.

The Huntington National Bank names Melissa Holding Director of Wealth Management

Retrieved on: 
목요일, 4월 25, 2024
Consumer, Huntington's disease, BB&T, Campbell University, Truist, Wealth management, Huntington Bancshares, Holding, Senior, Trust, MBA, Growth, Melissa

COLUMBUS, Ohio, April 25, 2024 /PRNewswire/ -- The Huntington National Bank announced today the appointment of Melissa Holding as Director of Wealth Management. Holding will oversee the Wealth Management business including private banking, wealth management and legacy planning through investment and portfolio management, fiduciary administration and trust services, institutional custody services, and full-service retail brokerage investments. Holding will focus on accelerating Huntington's continued growth and momentum in the wealth segment and will report to Consumer & Regional Banking President Brant Standridge.

Key Points: 
  • Holding will lead the bank's wealth business, succeeding Michael Robinson who will retire from Huntington
    COLUMBUS, Ohio, April 25, 2024 /PRNewswire/ -- The Huntington National Bank announced today the appointment of Melissa Holding as Director of Wealth Management.
  • Holding will oversee the Wealth Management business including private banking, wealth management and legacy planning through investment and portfolio management, fiduciary administration and trust services, institutional custody services, and full-service retail brokerage investments.
  • Holding will focus on accelerating Huntington's continued growth and momentum in the wealth segment and will report to Consumer & Regional Banking President Brant Standridge.
  • We are appreciative of how he has grown Huntington Private Bank and our wealth business and created an award-winning culture for our colleagues.

The Huntington National Bank Ranks No. 1 in Customer Satisfaction in Pennsylvania in the J.D. Power 2024 U.S. Retail Banking Satisfaction Study

Retrieved on: 
목요일, 4월 11, 2024
Consumer, Customer satisfaction, Region, Huntington Bancshares, Huntington's disease

COLUMBUS, Ohio, April 11, 2024 /PRNewswire/ -- The Huntington National Bank has earned the top ranking in customer satisfaction in Pennsylvania in the J.D. Power 2024 U.S. Retail Banking Satisfaction Study. This is the second consecutive year Huntington has received this recognition in Pennsylvania.

Key Points: 
  • COLUMBUS, Ohio, April 11, 2024 /PRNewswire/ -- The Huntington National Bank has earned the top ranking in customer satisfaction in Pennsylvania in the J.D.
  • Power 2024 U.S. Retail Banking Satisfaction Study.
  • In the 2024 study, Huntington was named the Best Retail Bank for Customer Satisfaction in Pennsylvania.
  • Power 2024 U.S. Retail Banking Satisfaction Study is based on responses from more than 100,000 retail banking customers of the largest banks in the U.S. regarding their experiences with their retail bank.

Veuu Announces Partnership with Huntington Bancshares Inc. to Enhance Health Care Revenue Systems

Retrieved on: 
수요일, 3월 13, 2024
HBI, Partnership, Fintech, Big data, Huntington Bancshares, Insurance, Huntington's disease, Microsoft Excel, Medical device

Tampa, Florida--(Newsfile Corp. - March 13, 2024) - Veuu, an innovative AI-powered healthcare FinTech founded by Terence Mills, has announced a strategic partnership with Huntington Bancshares Inc. (HBI).

Key Points: 
  • Tampa, Florida--(Newsfile Corp. - March 13, 2024) - Veuu, an innovative AI-powered healthcare FinTech founded by Terence Mills, has announced a strategic partnership with Huntington Bancshares Inc. (HBI).
  • This partnership signifies an alliance in the healthcare industry aimed at revolutionizing healthcare revenue systems.
  • Terence Mills, CEO of Veuu, presenting a keynote at Big Data AI World at Excel in London.
  • The partnership between HBI and Veuu is a testament to their shared commitment to addressing the complex challenges in healthcare, particularly in revenue cycle management.

Prilenia Names Jina Swartz, M.D. Ph.D., as Chief Medical Officer

Retrieved on: 
수요일, 4월 3, 2024
Health, Neurology, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, Medicine, United States of Europe, European Brain Council, DSM-IV codes, ALS, University, Huntington's disease, Merck, Fellow, Therapy, CMO, Multimedia, HD, Pharmaceutical industry

Ph.D., as its first Chief Medical Officer (CMO).

Key Points: 
  • Ph.D., as its first Chief Medical Officer (CMO).
  • In this role, Jina will lead all clinical development and medical affairs activities at Prilenia.
  • Ph.D., Chief Medical Officer at Prilenia (Photo: Business Wire)
    Jina has more than 30 years’ experience in both academic neurology practice and in global drug development at leading pharmaceutical companies and joins Prilenia from Exciva, a neurodegeneration-focused biotech, where she was Chief Medical Officer.
  • Ph.D., Chief Medical Officer of Prilenia.

MagnusCards Accessibility App Widens Reach by Offering Five New Languages

Retrieved on: 
월요일, 4월 1, 2024
CIBC, Partnership, Card deck, Metrolinx, Huntington Bancshares, Equity, Huntington's disease, Spectrum, San Francisco International Airport, Double-deck aircraft

MagnusCards app now available in five additional languages: French, Polish, Somali, Arabic, and Spanish

Key Points: 
  • MagnusCards app now available in five additional languages: French, Polish, Somali, Arabic, and Spanish
    TORONTO, April 1, 2024 /PRNewswire/ - MagnusCards by Magnusmode , the groundbreaking mobile app that makes environments and activities easier to navigate for autistic and neurodiverse people, is expanding to include five additional languages: French, Polish, Somali, Arabic and Spanish.
  • These new offerings mark another step forward in Magnusmode's journey to create more inclusive home and community living for all.
  • As we continue expanding our reach and influence, we're paving a path toward an accessible and inclusive world for all."
  • Huntington National Bank , a Magnusmode Inclusion Partner, sponsored the expansion of additional languages to the app.

The Huntington National Bank Honored by Consumer Bankers Association for Commitment to Workforce Development

Retrieved on: 
목요일, 3월 28, 2024
Huntington Bancshares, Consumer, HOPE, Small business, Volunteering, CBA, Huntington's disease, Consumer Bankers Association, Woman

COLUMBUS, Ohio, March 28, 2024 /PRNewswire/ -- The Huntington National Bank and its Lift Local Business program have been nationally recognized by the Consumer Bankers Association (CBA) with the 2024 Joe Belew Award. The award honors CBA member banks for their efforts to address pressing social and community issues, with this year's focus recognizing impactful programs that seek to improve workforce development and educational opportunities.

Key Points: 
  • COLUMBUS, Ohio, March 28, 2024 /PRNewswire/ -- The Huntington National Bank and its Lift Local Business program have been nationally recognized by the Consumer Bankers Association (CBA) with the 2024 Joe Belew Award.
  • Huntington's Lift Local Business program supports minority-, woman-, and veteran-owned small businesses throughout the business life cycle, from start-up to expansion.
  • At Huntington, we recognize that some small businesses face more challenges when it comes to receiving funding," said Brant Standridge, Huntington's Consumer and Regional Banking President.
  • The Joe Belew Award was established to honor former CBA President, Joe Belew, for his commitment to community development.

PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions

Retrieved on: 
화요일, 3월 12, 2024
Gene, Methylation, FTD, FMR1, ALS, Associate, Myotonic dystrophy, Abraxis BioScience, Huntington's disease, DNA, Apple IIe, Ataxia, Laboratory, University College London, Frontotemporal dementia, DSM-IV codes, Mosaic, High fidelity, Instability

MENLO PARK, Calif., March 12, 2024 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the PureTarget repeat expansion panel, a new solution designed to enable the comprehensive analysis of 20 genes associated with serious neurological disorders, including challenging-to-sequence genes with tandem repeat expansions. The new long-read workflow can minimize iterative analysis using legacy technology, and reduce the time needed to identify disease-causing variants and associated methylation signatures.

Key Points: 
  • "This product uses a differentiated method to do targeted long-read sequencing of DNA in its pure state.
  • Continuing the commitment to deliver comprehensive solutions, PacBio has prioritized delivering end-to-end workflows with their latest products.
  • The PureTarget Repeat Expansion Panel workflow utilizes the recently announced Nanobind PanDNA kit , ensuring robust results optimized for Revio and Sequel IIe users.
  • Customers can multiplex up to 48 samples on the PacBio Revio sequencing system and 24 samples on the PacBio Sequel IIe sequencing system.

The Huntington National Bank Partners with Ron Clark Academy to Ignite Local Classrooms

Retrieved on: 
월요일, 3월 11, 2024
Huntington Bancshares, Consumer, Classroom, Learning, Partnership, Education, Ron Clark (teacher), Society, Ronald Clark, Huntington's disease, Ron Clark Academy, Counselor, Tutoring

COLUMBUS, Ohio, March 11, 2024 /PRNewswire/ -- The Huntington National Bank has announced a new education-focused partnership with the Ron Clark Academy – the Ignite the Classroom initiative. The partnership is designed to support educators and help enhance student learning.

Key Points: 
  • COLUMBUS, Ohio, March 11, 2024 /PRNewswire/ -- The Huntington National Bank has announced a new education-focused partnership with the Ron Clark Academy – the Ignite the Classroom initiative.
  • Experience the full interactive Multichannel News Release here: https://www.multivu.com/players/English/9191051-huntington-national-bank...
    Huntington's partnership with the Ron Clark Academy aligns with the bank's commitment to strengthen the communities it serves.
  • "At the Ron Clark Academy, we know that when you affect the lives of teachers, you impact the lives of kids.
  • When our kids are well educated, we have educated societies and stronger communities," said Ron Clark, co-founder, Ron Clark Academy.